Lilly’s oral SERD gets FDA nod in advanced breast cancer

The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...
Zacks Investment Research on MSN

LLY Gets EU Approval for Alzheimer's Drug & FDA Nod to Cancer Therapy

Eli Lilly and Company LLY announced that the European Commission (EC) has granted marketing authorization to Kisunla ...

Ozempic gets India nod: Drug regulator approves Novo Nordisk's blockbuster diabetes drug

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...
Medscape

FDA gives nod to antiobesity effects of rimonabant but balks at smoking-cessation indication

Paris, France - The US Food and Drug Administration (FDA) has told Sanofi-Aventis that its cannaboid-1 (CB1) receptor blocker rimonabant is "approvable" as a weight-loss drug but not as a ...
Medical Dialogues

Eli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Inluriyo ...